0
0
Published: March 3, 2026
KOLKATA — In a discovery that is sending shockwaves through the global scientific community, researchers from India’s Bose Institute and Rutgers University in the United States have dismantled a foundational “rule” of biology that has been taught in classrooms for half a century. The study, published this week in the Proceedings of the National Academy of Sciences (PNAS), reveals that the way bacteria regulate their genes is far more diverse than previously believed—a finding that could pave the way for a new generation of high-precision antibiotics and sustainable biofuels.
For decades, the “Sigma ($\sigma$) Cycle” was considered a universal truth in microbiology. It described a specific handshake between molecules that allowed bacteria to survive, adapt, and cause infection. By proving this cycle is not universal, the joint research team has effectively “rewritten the textbook” on bacterial transcription.
The Breakdown of a Biological Dogma
To understand the significance of this breakthrough, one must look at the engine of the bacterial cell: RNA polymerase. This enzyme is responsible for transcription—the process of copying DNA into RNA, which the cell then uses to create proteins.
Since the 1970s, scientists believed that for transcription to start, a helper protein called a sigma factor had to bind to the RNA polymerase. According to the “Sigma Cycle” model, once the process moved past the starting line (initiation), the sigma factor would fall off (dissociate) to allow the enzyme to finish the job (elongation).
However, using cutting-edge biochemical assays and real-time fluorescence imaging, the team led by Dr. Jayanta Mukhopadhyay of the Bose Institute discovered that in certain bacteria, the sigma factor doesn’t let go.
“Our work shows that in Bacillus subtilis, the $\sigma^A$ factor stays attached to RNA polymerase all the way through the transcription process,” says Dr. Mukhopadhyay. “This fundamentally changes how we think about bacterial transcription and gene regulation.”
Challenging the E. coli Standard
Much of modern microbiology is based on the study of Escherichia coli (E. coli). The 50-year-old Sigma Cycle was modeled specifically on the E. coli $\sigma^{70}$ factor. The new research demonstrates that while E. coli might follow this rule, other bacteria—like the soil-dwelling Bacillus subtilis—do not.
The researchers found that a specific region of the sigma factor, known as “part 1.1,” acts like a release switch. In Bacillus subtilis, this switch operates differently, allowing the sigma factor to remain stably associated with the transcription complex throughout its entire journey along the DNA strand.
“These findings provide compelling evidence that the long-accepted $\sigma$ cycle does not apply to all bacteria,” explains Aniruddha Tewari, a co-author from the Bose Institute. “It opens new avenues for understanding bacterial gene regulation and its evolution.”
Why This Matters for Public Health
While “transcription initiation” may sound like abstract science, its implications for medicine are tangible and urgent. We are currently facing a global crisis of antibiotic resistance, where common bacteria are evolving to outsmart our current drugs.
1. Better Antibiotics
Many existing antibiotics work by targeting the bacterial transcription machinery. By identifying that different bacteria use different “mechanics” to regulate their genes, scientists can now design “narrow-spectrum” antibiotics. These would be “smart bombs” that target the specific transcription traits of a pathogen without killing the beneficial bacteria in a patient’s gut.
2. Fighting Infection Mechanisms
If the sigma factor stays attached, it may play a role in how bacteria respond to stress or move toward a host to cause infection. Blocking this specific, newly discovered pathway could prevent bacteria from “turning on” their virulence genes.
3. Green Technology
Beyond medicine, the discovery has massive implications for synthetic biology. By understanding the nuances of these genetic switches, bioengineers can better “program” microorganisms to produce:
-
High-efficiency biofuels to reduce carbon footprints.
-
Biodegradable plastics created by bacterial fermentation.
-
Complex therapeutic compounds for treating rare diseases.
Expert Perspectives and Limitations
“This is a classic example of why we must look beyond ‘model organisms’ like E. coli,” says Dr. Aris Katzourakis, an evolutionary biologist not involved in the study. “By assuming every bacterium followed the same rules, we may have been looking at the microbial world through a keyhole.”
However, experts caution that while this discovery is a milestone, it is not an immediate cure for any disease. “The leap from a laboratory biochemical assay to a shelf-ready antibiotic is a journey of 10 to 15 years,” notes Dr. Sarah Jenkins, a clinical microbiologist. “What this study provides is the map. Now, the pharmaceutical industry must build the vehicle.”
The study also raises new questions: If the sigma factor stays attached, does it hinder the speed of transcription? Or does it act as a “guide” to help the enzyme navigate complex genetic environments? These are the questions the Bose-Rutgers team plans to tackle next.
Conclusion
The collaboration between the Bose Institute (an autonomous institute of India’s Department of Science and Technology) and Rutgers University marks a proud moment for Indian science on the global stage. By challenging a half-century of scientific certainty, they have reminded the world that in biology, the “rules” are often just the beginning of the story.
As we move into an era of personalized medicine and sustainable bio-manufacturing, the “Sigma Cycle” may become a footnote, replaced by a more complex, accurate, and useful understanding of the microscopic world.
References
Primary Study:
-
Tewari, A., Sengupta, S., Mukherjee, S., Hazra, N., Ebright, Y. W., Ebright, R. H., & Mukhopadhyay, J. (2026). “Retention of the principal transcription initiation factor during transcription elongation in Bacillus subtilis.” Proceedings of the National Academy of Sciences (PNAS). DOI: 10.1073/pnas.2503801122.
-
Press Information Bureau (PIB) Delhi: “Indian scientists helped rewrite a 50-year-old biological rule,” March 2, 2026.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
